These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8128838)

  • 1. Cholinergic therapy in dementia.
    Whitehouse PJ
    Acta Neurol Scand Suppl; 1993; 149():42-5. PubMed ID: 8128838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of cholinesterase inhibitors in Alzheimer's disease.
    Håkansson L
    Acta Neurol Scand Suppl; 1993; 149():7-9. PubMed ID: 7907455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: effect of tacrine treatment.
    Nordberg A; Lundqvist H; Hartvig P; Andersson J; Johansson M; Hellstrŏm-Lindahi E; Långström B
    Dement Geriatr Cogn Disord; 1997; 8(2):78-84. PubMed ID: 9065319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of long-term treatment with tacrine (THA) in Alzheimer's disease as visualized by PET.
    Nordberg A
    Acta Neurol Scand Suppl; 1993; 149():62-5. PubMed ID: 8128843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on cholinergic enhancement therapy for Alzheimer disease.
    Read SL
    Bull Clin Neurosci; 1987; 52():34-7. PubMed ID: 3334548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel anticholinesterase THB013: biochemical and behavioural studies.
    Adem A; Mohammed AH; Winblad B; Henriksson BE
    J Neural Transm Park Dis Dement Sect; 1994; 8(1-2):139-48. PubMed ID: 7893376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Alzheimer's disease: an evaluation of the cholinergic approach.
    Lemière J; Van Gool D; Dom R
    Acta Neurol Belg; 1999 Jun; 99(2):96-106. PubMed ID: 10427352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and drug interactions of cholinesterase inhibitors administered in Alzheimer's disease.
    Crismon ML
    Pharmacotherapy; 1998; 18(2 Pt 2):47-54; discussion 79-82. PubMed ID: 9543465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Potential of Multifunctional Tacrine Analogues.
    Przybyłowska M; Kowalski S; Dzierzbicka K; Inkielewicz-Stepniak I
    Curr Neuropharmacol; 2019; 17(5):472-490. PubMed ID: 29651948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination of Alzheimer patients responding to cholinesterase inhibitor therapy.
    Alhainen K; Riekkinen PJ
    Acta Neurol Scand Suppl; 1993; 149():16-21. PubMed ID: 7907454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New drug interventions in Alzheimer's disease.
    Stern GM
    Curr Opin Neurol Neurosurg; 1992 Feb; 5(1):100-3. PubMed ID: 1623227
    [No Abstract]   [Full Text] [Related]  

  • 12. PET studies and cholinergic therapy in Alzheimer's disease.
    Nordberg A
    Rev Neurol (Paris); 1999; 155 Suppl 4():S53-63. PubMed ID: 10637939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maximizing function in Alzheimer's disease: what role for tacrine?
    Smucker WD
    Am Fam Physician; 1996 Aug; 54(2):645-52. PubMed ID: 8701842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cholinesterase inhibitors on learning and memory in rats: a brief review with special reference to THA.
    Mohammed AH
    Acta Neurol Scand Suppl; 1993; 149():13-5. PubMed ID: 8128832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Side effects of long acting cholinesterase inhibitors.
    Beermann B
    Acta Neurol Scand Suppl; 1993; 149():53-4. PubMed ID: 8128840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A risk-benefit assessment of tacrine in the treatment of Alzheimer's disease.
    Samuels SC; Davis KL
    Drug Saf; 1997 Jan; 16(1):66-77. PubMed ID: 9010644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
    Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J
    Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic delirium and neurotoxicity associated with tacrine for Alzheimer's dementia.
    Trzepacz PT; Ho V; Mallavarapu H
    Psychosomatics; 1996; 37(3):299-301. PubMed ID: 8849507
    [No Abstract]   [Full Text] [Related]  

  • 19. Tacrine: In vivo veritas.
    Jarrott B
    Pharmacol Res; 2017 Feb; 116():29-31. PubMed ID: 28040533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The next generation of cholinesterase inhibitors.
    Adem A
    Acta Neurol Scand Suppl; 1993; 149():10-2. PubMed ID: 8128831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.